Common Contracts

4 similar Merger Agreement contracts by Petra Acquisition Inc., Lifesci Acquisition II Corp.

LIFESCI CAPITAL LLC New York, New York 10019 November 20, 2020
Merger Agreement • November 25th, 2020 • Lifesci Acquisition II Corp. • Blank checks • New York

This is to confirm our agreement whereby LifeSci Acquisition II Corp., a Delaware corporation (“Company”), has requested LifeSci Capital LLC (“LifeSci”) and Ladenburg Thalmann & Co. Inc. (“Ladenburg”) (together, the “Advisors” and each an “Advisor”) to assist it in connection with the Company merging with, acquiring, engaging in a share exchange, recapitalization or reorganization, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination (in each case, a “Business Combination”) with one or more businesses or entities (each a “Target”) as described in the Company’s Registration Statement on Form S-1 (File No. 333- 249480) filed with the Securities and Exchange Commission (collectively, the “Registration Statement”) in connection with its initial public offering (“IPO”).

AutoNDA by SimpleDocs
LIFESCI CAPITAL LLC New York, New York 10019 October 7, 2020
Merger Agreement • October 13th, 2020 • Petra Acquisition Inc. • Blank checks • New York

This is to confirm our agreement whereby Petra Acquisition, Inc., a Delaware corporation (“Company”), has requested LifeSci Capital LLC (“LifeSci”), Ladenburg Thalmann & Co. Inc. (“Ladenburg”), Ingalls & Snyder LLC (“Ingalls”), and Northland Securities, Inc. (“Northland”), 277 Park Avenue, 26th Floor, New York, NY 10172, (together, the “Advisors” and each an “Advisor”) to assist it in connection with the Company merging with, acquiring, engaging in a share exchange, recapitalization or reorganization, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination (in each case, a “Business Combination”) with one or more businesses or entities (each a “Target”) as described in the Company’s Registration Statement on Form S-1 (File No. 333-240175) filed with the Securities and Exchange Commission (collectively, the “Registration Statement”) in connection with its initial public offering (“IPO”).

LIFESCI CAPITAL LLC New York, New York 10019
Merger Agreement • August 26th, 2020 • Petra Acquisition Inc. • Blank checks • New York

This is to confirm our agreement whereby Petra Acquisition, Inc., a Delaware corporation (“Company”), has requested LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc., 277 Park Avenue, 26th Floor, New York, NY 10172, (together, the “Advisors” and each an “Advisor”) to assist it in connection with the Company merging with, acquiring, engaging in a share exchange, recapitalization or reorganization, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination (in each case, a “Business Combination”) with one or more businesses or entities (each a “Target”) as described in the Company’s Registration Statement on Form S-1 (File No. 333-240175) filed with the Securities and Exchange Commission (collectively, the “Registration Statement”) in connection with its initial public offering (“IPO”).

LIFESCI CAPITAL LLC New York, New York 10019
Merger Agreement • July 29th, 2020 • Petra Acquisition Inc. • Blank checks • New York

This is to confirm our agreement whereby Petra Acquisition, Inc., a Delaware corporation (“Company”), has requested LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc., 277 Park Avenue, 26th Floor, New York, NY 10172, (together, the “Advisors” and each an “Advisor”) to assist it in connection with the Company merging with, acquiring, engaging in a share exchange, recapitalization or reorganization, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination (in each case, a “Business Combination”) with one or more businesses or entities (each a “Target”) as described in the Company’s Registration Statement on Form S-1 (File No. 333-[____]) filed with the Securities and Exchange Commission (collectively, the “Registration Statement”) in connection with its initial public offering (“IPO”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!